Trial intelligence / Profile preview

TP-03 for Demodex blepharitis

ISRCTN12449602Phase 2Completed

Sponsor
Roberto Gonzalez Salinas, MD
Start
Mar 2019
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of lotilaner, sponsored by Roberto Gonzalez Salinas, MD. Started Mar 2019; status: completed.

02

Drugs

lotilaner

Beyond the preview

Go deeper on ISRCTN12449602.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN12449602.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call